We predicted the NSCLC data using submap in genepatern to obtain the efficacy of anti-PD1 and anti-CTLA4 treatment, but the results showed no significant treatment (Fig. 5D). The gene discussed is CTLA4; the disease is non-small cell lung carcinoma.